Fig. 1
From: Preliminary study of the toxicity and radioprotective effects of zymosan in vitro and in vivo
The effect of zymosan on cell viability. a The viability of AHH-1 cells treated with different concentrations of zymosan (0, 20, 40, 80, or 160 μg/mL) for 24, 48 or 72 h. b The viability of HIECs treated with different concentrations of zymosan (0, 20, 40, 80, or 160 μg/mL) for 24, 48 or 72 h. The test was repeated 3 times. The data are expressed as the−X ± SD. ANOVA was used to analyze the data from the different groups